SCHEMBL25128158

SCHEMBL25128158

Cc1cccc(Cc2ccc(N)c(Cl)c2)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 4/20 0.69
▸ LTA4H P09960 1/20 0.48
▸ TAAR1 Q96RJ0 2/20 0.46
▸ IDO1 P14902 2/20 0.44
▸ POLB P06746 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ ALDH1A1 P00352 6/20 0.41
▸ KDM4E B2RXH2 3/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ MPO P05164 1/20 0.40
▸ DAO P14920 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ TSHR P16473 2/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Toluene SCHEMBL9700648 0.88 CYP3A4 (0.71) CYP3A4LTA4HPOLBMAPTALDH1A1
SCHEMBL43509 0.83 CYP3A4 (1.00) CYP3A4TAAR1IDO1POLBMAPT
SCHEMBL30097830 0.83 CYP3A4 (1.00) CYP3A4TAAR1IDO1POLBMAPT
SCHEMBL6351215 0.82 CYP3A4 (0.80) CYP3A4LTA4HPOLBMAPTALDH1A1
Ammonia Solution, Strong SCHEMBL9140534 0.81 CYP3A4 (0.95) CYP3A4TAAR1IDO1POLBMAPT
SCHEMBL8765734 0.81 CYP3A4 (0.95) CYP3A4TAAR1IDO1POLBMAPT
SCHEMBL12607303 0.80 CYP3A4 (0.77) CYP3A4POLBMAPTALDH1A1KDM4E
SCHEMBL10714891 0.80 CYP3A4 (0.83) CYP3A4POLBMAPTALDH1A1KDM4E
SCHEMBL8093804 0.79 TAAR1 (0.56) LTA4HTAAR1IDO1DAO
SCHEMBL30000562 0.79 TAAR1 (0.60) LTA4HTAAR1IDO1ALDH1A1DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023040793-A1 ANTI-INFLAMMATORY COMPOUND AND USE THEREOF 映恩生物制药(苏州)有限公司 2023-03-23 — — WO disclosed
Send feedback